GGrantIndex
Sort

17,054 grants matching genome editing

Advanced Molecular Probes and Cell Engineering Tools for Accurate Single-Molecule Analysis of Signaling in Individual Cells

$242,551
Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2022 · GM

Engineering picoviruses with defined host range to combat drug-resistant staphylococci

$242,450
Terje Dokland · University Of Alabama At Birmingham · R21 · FY2021 · AI

Dissecting the mechanism of pyrantel resistance in hookworm

$242,250
John M Hawdon · George Washington University · R21 · FY2023 · AI

A CRISPR-based modular transgenic system to advance in vivo investigations of angiogenesis and fibrosis

$242,250
Matthew J Wolf · University Of Virginia · R21 · FY2022 · OD

Split-GFP tagging and live imaging of hair cell proteins

$242,250
Jung-Bum Shin · University Of Virginia · R21 · FY2022 · DC

Using human intestinal organoids to model IBD pathogenesis

$242,250
Ophir D Klein · University Of California, San Francisco · R21 · FY2021 · DK

POSTTRANSCRIPTIONAL REGULATION OF SEROTONIN RECEPTORS

$242,235
Vanderbilt University · R01 · FY2001 · NS

Comprehensive Characterization of Adaptive Regulatory Variation Linked to Human Disease

$242,227
Steven K. Reilly · Yale University · R00 · FY2023 · HG

Development of a Fragile X Syndrome model in the gerbil to study auditory dysfunction

$242,176
Yuan Wang · Florida State University · R21 · FY2020 · DC

Antimicrobial peptides as models for the evolution of gene duplication

$242,115
Robert L Unckless · University Of Kansas Lawrence · R00 · FY2016 · GM

DNA damage responses to genome editing in hematopoietic stem cells

$242,048
Phillip A Doerfler · Versiti Blood Health, Inc. · R03 · FY2025 · DK

Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9

$241,926
Keith Thomas Gagnon · Wake Forest University Health Sciences · R01 · FY2023 · GM

Novel Experimental Model for Pseudoexfolliation Syndrome

$241,778
Pedro Gonzalez · Duke University · R21 · FY2018 · EY

Non-viral delivery of CRISPR/Cas9 for targeted gene replacement

$241,722
Christopher Nelson · University Of Arkansas At Fayetteville · R00 · FY2021 · EB

CAR mast cell for solid tumor

$241,713
Xiaolei Su · Yale University · R21 · FY2024 · CA

Selectable non-mosaic embryo editing

$241,696
Hiromitsu Nakauchi · Stanford University · R21 · FY2021 · OD

Functional assessment of enhancer-gene interactions in vivo

$241,680
Evgeny Kvon · University Of California-Irvine · R00 · FY2022 · HG

A novel blood-CSF adaptive immune response in Alzheimer's disease

$241,531
David Gate · Northwestern University At Chicago · R00 · FY2024 · NS

Precision Base Editing for the Treatment of Motor Neuron Diseases

$241,531
Mandana Arbab · Boston Children'S Hospital · R00 · FY2024 · NS

The Role of Fat in Osteoarthritis

$241,530
Kelsey Helen-Marie Collins · University Of California, San Francisco · R00 · FY2024 · AR

Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma

$241,528
Arupratan Das · Indiana University Indianapolis · R00 · FY2021 · EY

A novel and tractable model to address telomere dysfunction in a human tissue

$241,500
Frederick Bradley Johnson · University Of Pennsylvania · R21 · FY2016 · AG

Germ cell preservation of immunodeficient pigs utilizing embryo complementation approach

$241,500
Kiho Lee · Virginia Polytechnic Inst And St Univ · R21 · FY2019 · OD

Molecular Identity of Maternal Regulators of the Egg to Embryo Transition

$241,500
Mary C Mullins · University Of Pennsylvania · R21 · FY2017 · HD

Genetically enabling Hydra oligactis for comparative studies in development, regeneration and aging.

$241,500
Celina Juliano · University Of California At Davis · R21 · FY2024 · OD